摘要:
A computer-implemented system is provided for monitoring performance of a media player launched by a web browser. The media player is referenced by a document that defines a web page and is implemented as a plug-in to the web browser. Upon accessing the web page, the web browser launches the media player. The media player in turn launches a performance monitor that is implemented as a plug-in to the media player. The performance monitor subscribes to event listener objects exposed by the media player and receives event data that is reported by the event listener objects. Performance metrics pertaining to the media player are derived from the event data.
摘要:
A computer-implemented system is provided for monitoring performance of a media player launched by a web browser. The media player is referenced by a document that defines a web page and is implemented as a plug-in to the web browser. Upon accessing the web page, the web browser launches the media player. The media player in turn launches a performance monitor that is implemented as a plug-in to the media player. The performance monitor subscribes to event listener objects exposed by the media player and receives event data that is reported by the event listener objects. Performance metrics pertaining to the media player are derived from the event data.
摘要:
The present invention is directed to methods for treating, preventing, ameliorating, controlling or reducing the risk of a disorder or disease, which method comprises the administration to a patient of an effective amount of the compound of formula I: I (wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n and the dashed line are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
摘要翻译:本发明涉及治疗,预防,改善,控制或降低病症或疾病风险的方法,该方法包括向患者施用有效量的式I化合物:其中R为 R 1,R 2,R 3,R 4,R 5,R 4, R 6,R 7,R 8,R 9,R 10,X,n, 并且虚线在本文中定义),其可用作趋化因子受体活性的调节剂。 特别地,这些化合物可用作趋化因子受体CCR-2的调节剂。
摘要:
The present invention is directed to compounds of formulae (I and II) (wherein A, D, E, X, l, m, n and R1 through R18 are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
摘要:
The present invention is directed to methods for treating, preventing, ameliorating, controlling or reducing the risk of an inflammatory or immunoregulatory disorder or disease, which method comprises the administration to a patient of an effective amount of the compound of formula I: (wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n and the dashed line are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
摘要翻译:本发明涉及用于治疗,预防,改善,控制或降低炎性或免疫调节性疾病或疾病风险的方法,该方法包括向患者施用有效量的式I化合物:(其中R R 1,R 2,R 3,R 4,R 5,R 5,R 5, R 6,R 7,R 8,R 9,R 10,X 10, ,n和虚线在本文中定义),其可用作趋化因子受体活性的调节剂。 特别地,这些化合物可用作趋化因子受体CCR-2的调节剂。
摘要:
A method and system implementing application centric connectivity under various virtualization platforms are disclosed. According to one embodiment, a system comprises a virtual platform running on a physical machine; a virtual machine that hosts an application running on the virtual platform; a device binding module running on the virtual platform; a virtual device module running inside a virtual machine, a centralized management module running on datacenter management network. The binding module connects a virtual function of physical hardware interface card to the virtual machine and instructs the virtual device module to instantiate a virtual network device and a virtual storage device inside the virtual machine. The device binding module is in communication with the management module and receives updates from the management module and applies them to the virtual device in real time through the virtual device module. The management module ensures the consistent connectivity for an application in various virtualization platforms.
摘要:
Methods and apparatus are provided for virtualizing port adapter resources such as network interface cards (NICs) used to connect servers to packet based networks. Resources are offloaded from individual servers onto a resource virtualization switch. Servers connected to the resource virtualization switch using an I/O bus connection share access to NICs. Redundancy can be provided using multipathing mechanisms implemented at individual servers or high availability mechanisms implemented at the resource virtualization switch. Switchover can occur between ports on the same port adapter, between ports on separate adapters, or between ports on separate resource virtualization switches.
摘要:
Provided is a novel approach for connecting servers to peripherals, such as NICs, HBAs, and SAS/SATA controllers. Also provided are methods of arranging peripherals within one or more I/O directors, which are connected to the servers over an Ethernet network. Such arrangement allows sharing the same resource among multiple servers.
摘要:
Provided is a novel approach for connecting servers to peripherals, such as NICs, HBAs, and SAS/SATA controllers. Also provided are systems for arranging peripherals within one or more I/O directors, which are connected to the servers over an Ethernet network. Such arrangement allows sharing the same resource among multiple servers.
摘要:
Methods and apparatus are provided for virtualizing port adapter resources such as network interface cards (NICs) used to connect servers to packet based networks. Resources are offloaded from individual servers onto a resource virtualization switch. Servers connected to the resource virtualization switch using an I/O bus connection share access to NICs. Redundancy can be provided using multipathing mechanisms implemented at individual servers or high availability mechanisms implemented at the resource virtualization switch. Switchover can occur between ports on the same port adapter, between ports on separate adapters, or between ports on separate resource virtualization switches.